How to buy Teligent stock

Teligent is a drug manufacturers-specialty & generic business based in the US. Teligent shares (TLGT) are listed on the NASDAQ and all prices are listed in US Dollars. Teligent employs 142 staff and has a trailing 12-month revenue of around $46.3 million.

Teligent stock price (NASDAQ: TLGT)

Use our graph to track the performance of TLGT stocks over time.

Teligent shares at a glance

• Key figures

Information last updated 2022-02-13.

Latest market close	$0.03
52-week range	$0.00 - $0.00
50-day moving average more info button	$0.27
200-day moving average more info button	$0.45
Wall St. target price	$1.00
PE ratio more info button	N/A
Dividend yield more info button	N/A (0%)
Earnings per share (TTM) more info button	$-4.31

Buy Teligent stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Teligent stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Teligent price performance over time

Historical closes compared with the close of $0.029 from 2021-12-17

1 week (2023-05-21)	N/A
1 month (2023-04-27)	N/A
3 months (2023-02-25)	N/A
6 months (2022-11-27)	N/A

1 year (2022-05-28)	N/A
2 years (2021-06-01)	-94.91%
3 years (2020-06-01)	3.56
5 years (2018-06-01)	28.9

Is Teligent stock undervalued or overvalued?

Valuing Teligent stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Teligent's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Teligent financials

Revenue TTM	$46.3 million
Gross profit TTM	$-3,722,000
Return on assets TTM	-19.58%
Return on equity TTM	0%
Profit margin	-197.78%
Book value	$0.19
Market capitalisation more info button	$16.1 million

TTM: trailing 12 months

Teligent share dividends

We're not expecting Teligent to pay a dividend over the next 12 months.

Have Teligent's shares ever split?

Teligent's shares were split on a 1:10 basis on 28 May 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Teligent shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Teligent shares which in turn could have impacted Teligent's share price.

Teligent share price volatility

Over the last 12 months, Teligent's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Teligent's is 1.6943. This would suggest that Teligent's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Teligent overview

Teligent, Inc. , a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc.

Frequently asked questions

What percentage of Teligent is owned by insiders or institutions?
Currently 0.039% of Teligent shares are held by insiders and 13.009% by institutions. How many people work for Teligent?
Latest data suggests 142 work at Teligent. When does the fiscal year end for Teligent?
Teligent's fiscal year ends in December. Where is Teligent based?
Teligent's address is: 105 Lincoln Avenue, Buena, NJ, United States, 08310 What is Teligent's ISIN number?
Teligent's international securities identification number is: US87960W2035 What is Teligent's CUSIP number?
Teligent's Committee on Uniform Securities Identification Procedures number is: 449575109